Dantron (chrysazin; 1,8-dihydroxyanthraquinone)
- PMID: 2292802
- PMCID: PMC7681542
Dantron (chrysazin; 1,8-dihydroxyanthraquinone)
Erratum in
- IARC Monogr Eval Carcinog Risks Hum 1994;59:257
Similar articles
-
Danthron (1,8-dihydroxyanthraquinone).Rep Carcinog. 2004;11:III77-8. Rep Carcinog. 2004. PMID: 21089845 No abstract available.
-
Sennosides and aloin do not promote dimethylhydrazine-induced colorectal tumors in mice.Pharmacology. 1993 Oct;47 Suppl 1:205-8. doi: 10.1159/000139859. Pharmacology. 1993. PMID: 8234430
-
Ultrastructure of mouse intestinal mucosa and changes observed after long term anthraquinone administration.Gut. 1984 Dec;25(12):1358-63. doi: 10.1136/gut.25.12.1358. Gut. 1984. PMID: 6510768 Free PMC article.
-
Metabolism and pharmacokinetics of anthranoids.Pharmacology. 1993 Oct;47 Suppl 1:86-97. doi: 10.1159/000139847. Pharmacology. 1993. PMID: 8234447 Review.
-
Disperse Blue 1.IARC Monogr Eval Carcinog Risks Hum. 1990;48:139-48. IARC Monogr Eval Carcinog Risks Hum. 1990. PMID: 2197456 Free PMC article. Review. No abstract available.
Cited by
-
Marine Anthraquinones: Pharmacological and Toxicological Issues.Mar Drugs. 2021 May 13;19(5):272. doi: 10.3390/md19050272. Mar Drugs. 2021. PMID: 34068184 Free PMC article. Review.
-
Safety of hydroxyanthracene derivatives for use in food.EFSA J. 2018 Jan 23;16(1):e05090. doi: 10.2903/j.efsa.2018.5090. eCollection 2018 Jan. EFSA J. 2018. PMID: 32625659 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources